Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for MaxCyte Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
B
BlackRock, Inc.
|
3.1M | 2.97% | −5.7M (−65.2%) | 2021 | 0.0% | |
|
Shares held by quarter
Peak holding10.2M (Q2'25)
Change over 8 quarters−5.4M
Share of the company2.970%
|
||||||
|
CF
Capricorn Fund Managers Ltd
|
8.2M | 7.95% | Unchanged | Q1 '26 | 0.8% | |
|
Shares held by quarter
Peak holding8.2M (Q1'26)
Change over 8 quarters+8.2M
Share of the company7.950%
|
||||||
28 more super investors behind a free account
See every manager holding MaxCyte Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$3.37M | 2.7M | 2.66% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$1.78M | 2.5M | 2.45% | 0.00% | March 31, 2026 |
23 more funds behind a free account
See every fund holding MaxCyte Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
LI
Liontrust Investment Partners LLP
5%+ holder
13D · 5.0%
|
5.2M | 5.03% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
RG
River Global Investors LLP
5%+ holder
13D · 0.8%
|
834.1K | 0.81% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
Loading...